FRNRX | GHAAX | FRNRX / GHAAX | |
Total Expense Ratio | 1.01 | 1.38 | 73% |
Annual Report Gross Expense Ratio | 1.02 | 1.49 | 68% |
Fund Existence | 30 years | 31 years | - |
Gain YTD | 22.658 | 28.603 | 79% |
Front Load | 6% | 6% | 96% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 362M | 530M | 68% |
Annual Yield % from dividends | 1.98 | 2.31 | 86% |
Returns for 1 year | 14.60 | 17.71 | 82% |
Returns for 3 years | 38.06 | 22.83 | 167% |
Returns for 5 years | 166.24 | 79.18 | 210% |
Returns for 10 years | 47.94 | 59.05 | 81% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFGY | 38.32 | 0.50 | +1.32% |
YieldMax Crypto Industry & Tech Portfolio Option Income ETF | |||
SOVF | 30.33 | 0.19 | +0.62% |
Sovereign's Capital Flourish Fund | |||
USCA | 41.36 | N/A | N/A |
Xtrackers MSCI USA Clmt Actn Eq ETF | |||
FTXH | 29.33 | -0.07 | -0.25% |
First Trust Nasdaq Pharmaceuticals ETF | |||
TSLQ | 8.06 | -0.21 | -2.54% |
Tradr 2X Short TSLA Daily ETF |